MIRA (STOCKS)
MIRA Pharmaceuticals, Inc. Common Stock
$1.040000
+0.043500 (+4.37%)
Prev close: $0.996500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Erez Aminov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $43.28M
- Employees
- 5
- P/E (TTM)
- -0.68
- P/B (TTM)
- 4.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | $50.63K |
| Operating Expenses | $10.49M |
| Research and Development | $1.72M |
| Other Operating Expenses | $8.77M |
| Income/Loss From Continuing Operations After Tax | -$10.44M |
| Income/Loss From Continuing Operations Before Tax | -$10.44M |
| Interest Income/Expense After Provision For Losses | $98.91K |
| Interest Income/Expense Operating, Net | $98.91K |
| Net Income/Loss | -$10.44M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.44M |
| Net Income/Loss Available To Common Stockholders, Basic | -$32.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $21.56M |
| Preferred Stock Dividends And Other Adjustments | $21.56M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.35 |
| Diluted Earnings Per Share | -$1.35 |
| Basic Average Shares | 23,694,333 |
| Assets | $11.09M |
| Current Assets | $11.06M |
| Prepaid Expenses | $28.15K |
| Other Current Assets | $11.03M |
| Noncurrent Assets | $35.44K |
| Liabilities | $702.07K |
| Current Liabilities | $702.07K |
| Accounts Payable | $129.20K |
| Wages | $572.87K |
| Noncurrent Liabilities | $0.00 |
| Equity | $10.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.39M |
| Liabilities And Equity | $11.09M |
| Net Cash Flow From Operating Activities | -$4.66M |
| Net Cash Flow From Operating Activities, Continuing | -$4.66M |
| Net Cash Flow From Investing Activities | -$3.51M |
| Net Cash Flow From Investing Activities, Continuing | -$3.51M |
| Net Cash Flow From Financing Activities | $8.18M |
| Net Cash Flow From Financing Activities, Continuing | $8.18M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$10.44M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.44M |
| Other Comprehensive Income/Loss | $0.00 |